Y Intercept Hong Kong Ltd Sells 41,473 Shares of Teleflex Incorporated $TFX

Y Intercept Hong Kong Ltd lowered its position in Teleflex Incorporated (NYSE:TFX) by 82.1% during the 3rd quarter, HoldingsChannel reports. The firm owned 9,068 shares of the medical technology company’s stock after selling 41,473 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Teleflex were worth $1,110,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB grew its position in Teleflex by 57.9% during the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock worth $26,000 after buying an additional 77 shares in the last quarter. True Wealth Design LLC boosted its position in shares of Teleflex by 10,333.3% during the 2nd quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock valued at $37,000 after acquiring an additional 310 shares during the last quarter. Quent Capital LLC bought a new stake in shares of Teleflex during the 3rd quarter valued at about $38,000. Salomon & Ludwin LLC purchased a new position in shares of Teleflex during the third quarter worth about $49,000. Finally, Farther Finance Advisors LLC increased its position in shares of Teleflex by 151.9% in the third quarter. Farther Finance Advisors LLC now owns 408 shares of the medical technology company’s stock worth $50,000 after purchasing an additional 246 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

TFX stock opened at $104.40 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57. The firm has a market cap of $4.61 billion, a P/E ratio of -14.20, a P/E/G ratio of 1.38 and a beta of 0.93. The firm’s fifty day moving average is $116.10 and its 200 day moving average is $119.60. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $184.34.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.38 by $0.29. The firm had revenue of $892.90 million for the quarter, compared to analysts’ expectations of $892.79 million. Teleflex had a positive return on equity of 15.64% and a negative net margin of 10.28%.The company’s revenue for the quarter was up 19.4% compared to the same quarter last year. During the same period last year, the firm earned $3.49 earnings per share. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. Research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, December 15th. Shareholders of record on Friday, November 14th were paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend was Friday, November 14th. Teleflex’s payout ratio is -18.50%.

Wall Street Analyst Weigh In

TFX has been the topic of a number of recent analyst reports. Truist Financial raised their target price on shares of Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research note on Thursday, December 18th. Wall Street Zen cut shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Wells Fargo & Company reduced their target price on Teleflex from $139.00 to $116.00 and set an “equal weight” rating on the stock in a research note on Thursday. Finally, Needham & Company LLC upgraded Teleflex from a “hold” rating to a “buy” rating and set a $138.00 price target on the stock in a research report on Tuesday. Two investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $139.00.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.